Synthace Overview

  • Founded

  • 2011

Founded
  • Status

  • Private

  • Employees

  • 90

Employees
  • Latest Deal Type

  • Series C

  • Latest Deal Amount

  • $35.5M

  • Investors

  • 19

Synthace General Information

Description

Developer of a laboratory automation platform designed to reshape biological experimentation. The company's platform removes the wrangling of lab data through the dynamic generation, capture and structuring of data with metadata, connects the experiment with other tools in the digital ecosystem and helps to plan and execute multifactorial experiments, enabling biologists to conduct codeless reprogramming of liquid handlers and visual stimulation before executing experiments.

Contact Information

Website
www.synthace.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Automation/Workflow Software
Business/Productivity Software
Primary Office
  • The Westworks
  • 195 Wood Lane
  • London W12 7FQ
  • England, United Kingdom
+44 020 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synthace Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series C) 16-Nov-2021 $35.5M 000.00 00000 Completed Generating Revenue
10. Accelerator/Incubator 23-Jan-2019 000.00 Completed Generating Revenue
9. Later Stage VC (Series B) 12-Dec-2018 000.00 000.00 000.00 Completed Generating Revenue
8. Later Stage VC 23-May-2018 00.00 0000 Completed Generating Revenue
7. Grant 01-Dec-2017 00000 000.00 Completed Generating Revenue
6. Later Stage VC (Series A) 01-Sep-2017 00.00 000.00 000.00 Completed Generating Revenue
5. Early Stage VC 05-Jan-2015 00.000 00.000 000.00 Completed Generating Revenue
4. Seed Round 24-Sep-2013 00.000 00.000 00.000 Completed Generating Revenue
3. Angel (individual) 12-Apr-2013 $944K Completed Generating Revenue
2. Grant 07-Mar-2013 $767K $944K Completed Generating Revenue
To view Synthace’s complete valuation and funding history, request access »

Synthace Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C2 Preferred 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series C1 Preferred 0,000,000 00.000000 00.00 00.00 00 00.00 0.00
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
2017 Convertible Preference 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
2017 Convertible Preference 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
2017 Convertible Preference 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Convertible Preference 3,796,414 $0.001363 $0.68 $0.68 1x $0.68 4.84%
Ordinary 652,261 $0.001363 $0.68 $0.68 3x $0.68 0.83%
To view Synthace’s complete cap table history, request access »

Synthace Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a laboratory automation platform designed to reshape biological experimentation. The company's platform rem
Other Healthcare Technology Systems
London, United Kingdom
90 As of 2023
000.00
0000 0000-00-00
00000000000 000.00

000000

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dol
00000 0000000000 000
Berlin, Germany
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

000000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
00000000 00000000
Boston, MA
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synthace Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Labforward Venture Capital-Backed Berlin, Germany 00 000.00 00000000000 000.00
000000000000 Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
00000000 Formerly VC-backed Basel, Switzerland 000 00000000000
00000000 Private Equity-Backed Chicago, IL 000000000000
0000000 00000000 Formerly VC-backed London, United Kingdom 0 00.000 000000&0 00.000
You’re viewing 5 of 8 competitors. Get the full list »

Synthace Patents

  • 23

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Synthace Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4085257-A1 Systems and methods for improved automation of laboratory processes Pending 31-Dec-2019 00000000000
GB-201919469-D0 Systems and methods for improved liquid handling for automation of laboratory processes Inactive 31-Dec-2019 00000000000
US-20220326265-A1 Systems and methods for improved automation of laboratory processes Pending 31-Dec-2019 00000000000
GB-201504876-D0 System and apparatus 2 Inactive 23-Mar-2015
GB-201405245-D0 System and apparatus 2 Inactive 24-Mar-2014
To view Synthace’s complete patent history, request access »

Synthace Executive Team (14)

Name Title Board Seat Contact Info
Guy Levy-Yurista Ph.D Chief Executive Officer & Board Member
Nick McCleery Chief Financial Officer
Markus Gershater Ph.D Co-Founder, Chief Scientific Officer & Board Member
Mathieu Ayel Chief Product Officer
Donald Deieso Ph.D Chairman
You’re viewing 5 of 14 executive team members. Get the full list »

Synthace Board Members (14)

Name Representing Role Since
Donald Deieso Ph.D Self Chairman 000 0000
Guy Levy-Yurista Ph.D Synthace Chief Executive Officer & Board Member 000 0000
Markus Gershater Ph.D Synthace Co-Founder, Chief Scientific Officer & Board Member 000 0000
Patrick Zhang Horizons Ventures Board Member 000 0000
Susan Shiff Ph.D Synthace Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Synthace Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synthace Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
David Lucas Angel (individual) Minority 000 0000 000000 0
Future Planet Capital Venture Capital Minority 000 0000 000000 0
Razor Capital Venture Capital Minority 000 0000 000000 0
Plug and Play Tech Center Accelerator/Incubator 000 0000 000000 0
ICONIQ Growth Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »

Ready to get started?

Request a free trial